Late-Breaking Clinical Trials
The ACC is currently accepting submissions of Late-Breaking Clinical Trials for presentation at ACC.18 in Orlando, FL. The deadline for all submissions is Wednesday, Dec. 6, 2017.
Submit your research in any of the following categories:
- Major Study
- Smaller Study/Randomized Clinical Trial
- Multi-center Observational Study or Registry
- Secondary Analysis of Major Clinical Trial
Accepted Late-Breaking Clinical Trial submissions will be presented in the ACC.18 Main Tent during one of five LBCT sessions. Three LBCT sessions will be co-sponsored by the Journal of the American College of Cardiology (JACC), the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM). Each accepted submission will be considered for JACC Rapid Review and publication in JACC, JAMA and NEJM. In addition, each LBCT session will be followed by a press conference with top media outlets. In 2017 Late-Breaking Clinical Trials, general abstracts and other meeting activities were covered in more than 3,000 unique articles, creating billions of media impressions.